首页> 美国卫生研究院文献>PLoS Clinical Trials >Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands
【2h】

Characterization of the Raf Kinase Inhibitory Protein (RKIP) Binding Pocket: NMR-Based Screening Identifies Small-Molecule Ligands

机译:Raf激酶抑制蛋白(RKIP)结合口袋的表征:基于NMR的筛选确定小分子配体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRaf kinase inhibitory protein (RKIP), also known as phoshaptidylethanolamine binding protein (PEBP), has been shown to inhibit Raf and thereby negatively regulate growth factor signaling by the Raf/MAP kinase pathway. RKIP has also been shown to suppress metastasis. We have previously demonstrated that RKIP/Raf interaction is regulated by two mechanisms: phosphorylation of RKIP at Ser-153, and occupation of RKIP's conserved ligand binding domain with a phospholipid (2-dihexanoyl-sn-glycero-3-phosphoethanolamine; DHPE). In addition to phospholipids, other ligands have been reported to bind this domain; however their binding properties remain uncharacterized.
机译:背景Raf激酶抑制蛋白(RKIP),也称为磷脂酰乙醇胺结合蛋白(PEBP),已显示抑制Raf,从而通过Raf / MAP激酶途径负调控生长因子信号传导。 RKIP也已显示可抑制转移。我们以前已经证明RKIP / Raf相互作用受两种机制调控:RKIP在Ser-153上的磷酸化,以及RKIP保守的配体结合结构域被磷脂(2-二己酰基-sn-甘油-3-磷酸乙醇胺; DHPE)占据。据报道,除磷脂外,其他配体也可结合该结构域。然而,它们的结合性质仍未表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号